VANESSA BROSAN: Open Payments
NPI 1598117079 · WENDELL, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,680 in 126 payments from 19 companies in 2025. Trend: 2023 $1,429 · 2024 $2,192 · 2025 $2,680
Food & beverage: $2,635Education: $45
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $631 |
| Bayer Healthcare Pharmaceuticals Inc. | 18 | $498 |
| Amgen Inc. | 25 | $344 |
| ABBVIE INC. | 17 | $286 |
| Novo Nordisk Inc | 13 | $233 |
| GlaxoSmithKline, LLC. | 10 | $147 |
| Lilly USA, LLC | 7 | $136 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $86 |
| Viatris Specialty LLC | 4 | $68 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $53 |
Products named: Kerendia, AIRSUPRA, VRAYLAR, FARXIGA, OTEZLA, TRELEGY ELLIPTA, REPATHA, Ozempic.
Industry payments across NC — which companies pay providers there.
